$235.38
Price
$14.8B
Market Cap
1961.5
P/E Ratio
9.1
Forward P/E
$0.12
EPS (TTM)
—
Dividend Yield
$2.9B
Cash
$5.4B
Total Debt
63M
Shares Out
$105.00
$243.32
52-Week Range
Institutional Ownership of JAZZ PHARMACEUTICALS PLC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for JAZZ PHARMACEUTICALS PLC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for JAZZ PHARMACEUTICALS PLC
6 Months Insider Sentiment
Buy $0
Sell $1.2M
0
Buys
3
Sells
-1.2M
Net
0
Grants
Largest
$770K
Carr
$633K
Carr
$379K
Henderson
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 09, 2025 | Mary Elizabeth Henderson | SVP, Technical Operations | SELL | 2.2K | $169.51 | $379K |
| Dec 05, 2025 | Patricia Carr | SVP, Chief Accounting Officer | EXERCISE | 4.5K | $140.67 | $633K |
| Dec 05, 2025 | Patricia Carr | SVP, Chief Accounting Officer | SELL | 160 | $171.11 | $27K |
| Dec 05, 2025 | Patricia Carr | SVP, Chief Accounting Officer | SELL | 4.5K | $171.20 | $770K |